Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 11 of 23
Dillico
Dillico
Angelor
France
Active
Sector
Biotech
InvestorANGELOR
Entry
2024
Hold
2yr
DNTOX
DNTOX
HTGF IV
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2023
Hold
3yr
Draig Therapeutics
Draig Therapeutics
SV7 Impact Medicine Fund
UK
Active
Sector
Biotech
InvestorSV Health Managers
Entry
2025
Hold
1yr
DunAD Therapeutics
DunAD Therapeutics
Wellington Partners Life Sciences
United Kingdom
Active
Sector
Biotech
InvestorWellington Partners
Entry
2021
Hold
5yr
Dynamic42
Dynamic42
Thueringer Startup-Fonds (TSF)
Germany
Active
Sector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2020
Hold
6yr
Dynamic42 GmbH
Dynamic42 GmbH
Thueringer Startup-Fonds (TSF)
Germany
Active
Sector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2019
Hold
7yr
Elastrin Therapeutics
Elastrin Therapeutics
KIZOO Evergreen (Balance Sheet)
United States
Active
Sector
Biotech
InvestorKIZOO Technology Capital
Entry
2021
Hold
5yr
Emulseo
Emulseo
ACI (Aquitaine Creation Investissement)
France
Active
Sector
Biotech
InvestorAquiti Gestion
Entry
2017
Hold
9yr
Engrail Therapeutics
Engrail Therapeutics
Ysios BioFund III
US
Active
Sector
Biotech
InvestorYsios Capital Partners
Entry
2024
Hold
2yr
EnsiliTech
EnsiliTech
Elbow Beach Capital
UK
Active
Sector
Biotech
InvestorElbow Beach Investments
Entry
2023
Hold
3yr
Entelo Bio
Entelo Bio
Ananda Impact Fund IV
Germany
Active
Sector
Biotech
InvestorAnanda Impact Ventures
Entry
2024
Hold
2yr
EnteroBiotix
EnteroBiotix
Scottish National Investment Bank (Balance Sheet)
UK
Active
Sector
Biotech
InvestorScottish National Investment Bank
Entry
2024
Hold
2yr
Enterprise Therapeutics
Enterprise Therapeutics
Panakes Fund Purple
United Kingdom
Active
Sector
Biotech
InvestorPanakes Partners SGR
Entry
2024
Hold
2yr
Enthera
Enthera
Atlante Seed
Italy
Active
Sector
Biotech
InvestorIndaco Venture Partners SGR
Entry
2020
Hold
6yr
EpiBiologics
EpiBiologics
Mubadala Capital Other Investments
USA
Active
Sector
Biotech
InvestorMubadala Capital
Entry
–
EpiBone
EpiBone
EMV Capital Evergreen Fund
United States
Active
Sector
Biotech
InvestorEMV Capital
Entry
2020
Hold
6yr
Epigenomics AG
Epigenomics AG
Deutsche Balaton Evergreen Holding (Balance Sheet)
Germany
Active
Sector
Biotech
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2018
Hold
8yr
Epitopea
Epitopea
CIC Fund II
UK
Active
Sector
Biotech
InvestorCambridge Innovation Capital
Entry
2022
Hold
4yr
Epsilogen
Epsilogen
ALSA Ventures European Biotechnology Fund
UK
Active
Sector
Biotech
InvestorALSA Ventures
Entry
2018
Hold
8yr
Eternygen
Eternygen
VC Fonds Technologie Berlin
Germany
Active
Sector
Biotech
InvestorIBB Ventures
Entry
2012
Hold
14yr
Etheros
Etheros
Backed Fund III
UK
Active
Sector
Biotech
InvestorBACKED VC
Entry
2023
Hold
3yr
Evox Therapeutics
Evox Therapeutics
Oxford Science Enterprises Balance Sheet
UK
Active
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2016
Hold
10yr
Extend
Extend
Angelini Ventures
Italy
Active
Sector
Biotech
InvestorAngelini Ventures
Entry
2022
Hold
4yr
FabricNano
FabricNano
Backed Fund II
UK
Active
Sector
Biotech
InvestorBACKED VC
Entry
2019
Hold
7yr
FibroFind
FibroFind
Vespa Capital III
UK
Active
Sector
Biotech
InvestorVespa Capital
Entry
2025
Hold
1yr
Focal Biosciences
Focal Biosciences
Apollo Health Ventures Fund II
Switzerland
Active
Sector
Biotech
InvestorApollo Health Ventures
Entry
2022
Hold
4yr
Formycon
Formycon
Athos Evergreen Life Sciences
Germany
Active
Sector
Biotech
InvestorAthos
Entry
2022
Hold
4yr
Freya Therapeutics
Freya Therapeutics
Angelini Ventures
Denmark
Active
Sector
Biotech
InvestorAngelini Ventures
Entry
2023
Hold
3yr
Gandeeva Therapeutics
Gandeeva Therapeutics
Leaps by Bayer
Canada
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2022
Hold
4yr
Gemma Biotherapeutics
Gemma Biotherapeutics
Earlybird Health
United States
Active
Sector
Biotech
InvestorEarlybird Venture Capital
Entry
2024
Hold
2yr
Genbioma
Genbioma
Start Up Capital Navarra
Spain
Active
Sector
Biotech
InvestorSodena
Entry
2019
Hold
7yr
Genetix Biotherapeutics
Genetix Biotherapeutics
The Carlyle Group Portfolio
USA
Active
Sector
Biotech
InvestorThe Carlyle Group
Entry
–
GenoME Diagnostics
GenoME Diagnostics
Co-Fund NI
UK
Active
Sector
Biotech
InvestorClarendon Fund Managers
Entry
2023
Hold
3yr
Georgiamune
Georgiamune
Mubadala Capital Other Investments
USA
Active
Sector
Biotech
InvestorMubadala Capital
Entry
–
Glen Clova Scientific
Glen Clova Scientific
DSW Ventures
UK
Active
Sector
Biotech
InvestorDSW Venture Capital
Entry
2024
Hold
2yr
Glox Therapeutics
Glox Therapeutics
Boehringer Ingelheim Venture Fund
United Kingdom
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2023
Hold
3yr
Gordian
Gordian
10x Founders Fund I
United States
Active
Sector
Biotech
Investor10x Founders
Entry
2021
Hold
5yr
Green Elephant Biotech GmbH
Green Elephant Biotech GmbH
Technologiefonds Hessen
Germany
Active
Sector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2022
Hold
4yr
Haptena Therapeutics
Haptena Therapeutics
Claris Biotech I
Italy
Active
Sector
Biotech
InvestorClaris Ventures SGR
Entry
2025
Hold
1yr
Harness Therapeutics
Harness Therapeutics
Dementia Discovery Fund
UK
Active
Sector
Biotech
InvestorSV Health Managers
Entry
2020
Hold
6yr
Hawk Cell
Hawk Cell
Angelor
France
Active
Sector
Biotech
InvestorANGELOR
Entry
2024
Hold
2yr
Heidelberg Pharma
Heidelberg Pharma
dievini Hopp BioTech holding (Evergreen Balance Sheet)
Germany
Active
Sector
Biotech
Investordievini Hopp BioTech holding
Entry
2009
Hold
17yr
Helical
Helical
Frst 3
Active
Sector
Biotech
InvestorFRST Capital
Entry
2024
Hold
2yr
Heqet Therapeutics
Heqet Therapeutics
Claris Biotech I
Italy
Active
Sector
Biotech
InvestorClaris Ventures SGR
Entry
2022
Hold
4yr
Heqet Therapeutics S.r.l.
Heqet Therapeutics S.r.l.
Deutsche Balaton Evergreen Holding (Balance Sheet)
Italy
Active
Sector
Biotech
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2022
Hold
4yr
Highlight Therapeutics
Highlight Therapeutics
Columbus Life Science Fund II
Spain
Active
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2020
Hold
6yr
Histocell
Histocell
Fondo BI
Spain
Active
Sector
Biotech
InvestorSeed Capital de Bizkaia
Entry
2015
Hold
11yr
HTL
HTL
NIO I
France
Active
Sector
Biotech
InvestorNaxicap Partners
Entry
2017
Hold
9yr
Ikarovec
Ikarovec
LifeArc Ventures
UK
Active
Sector
Biotech
InvestorLifeArc
Entry
2020
Hold
6yr
Ilios Therapeutics
Ilios Therapeutics
Vento Fund I
United States
Active
Sector
Biotech
InvestorVento
Entry
2023
Hold
3yr